Comment: Inverse association for risk of ALS and risk of all cancers
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Amyotrophic lateral sclerosis (ALS) is likely caused by an interaction among genetic, environmental, and age-dependent risk factors, with evidence to suggest mechanisms similar to carcinogenesis.1 The genetic contribution to familial ALS and ethnic differences in ALS incidence suggest there may be a genetic predisposition also to sporadic disease—90% to 95% of ALS cases. As Gibson et al.2 point out, some of the genes implicated in familial ALS are oncogenes, yet no association has been found between the occurrence of ALS and cancers in general.
Footnotes
Study funding: No targeted funding reported.
Disclosure: The author reports no disclosures. Go to Neurology.org for full disclosures.
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Victoria Leavitt and Dr. Laura Hancock
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Population-based risks for cancer in patients with ALSSummer B. Gibson, Diana Abbott, James M. Farnham et al.Neurology, May 11, 2016 -
Articles
Lifetime occupation, education, smoking, and risk of ALSN. A. Sutedja, J. H. Veldink, K. Fischer et al.Neurology, October 08, 2007 -
Article
High BMI is associated with low ALS riskA population-based studyOla Nakken, Haakon E. Meyer, Hein Stigum et al.Neurology, June 26, 2019 -
Null Hypothesis
Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosisKjetil Bjornevik, Zhongli Zhang, Éilis J. O'Reilly et al.Neurology, March 29, 2019